Inclusion complexes of a nucleotide analogue with hydroxypropyl-beta- cyclodextrin

Journal of Inclusion Phenomena and Macrocyclic Chemistry

Volumn 63, Issue 1-2, 2009, Pages 11-16

  Jordheim, Lars Petter ^a   Degobert, Ghania ^b   Diab, Roudayna ^b   Peyrottes, Suzanne ^c   Périgaud, Christian ^c   Dumontet, Charles ^a   Fessi, Hatem ^b  

^a UNIVERSITÉ LYON 1   (France)

^b UNIVERSITÉ LYON 1   (France)

^c UNIVERSITÉ DE MONTPELLIER   (France)

Author keywords

2 Hydroxypropyl beta cyclodextrin; AraC; Deoxynucleoside analogues; In vivo; Inclusion complexes; Pronucleotide

Indexed keywords

EID: 58549119339     PISSN: 09230750     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10847-008-9483-8     Document Type: Article

References (13)

1. LP Jordheim C Dumontet 2007 Review of recent studies on resistance to cytotoxic deoxynucleoside analogues Biochim. Biophys. Acta 1776 138 159
2. LP Jordheim CM Galmarini C Dumontet 2006 Recent developments to improve the efficacy of cytotoxic nucleoside analogues. Recent patents anticancer Drug Discov. 1 163 170 10.2174/157489206777442205
3. CM Galmarini ML Clarke CL Santos L Jordheim C Perigaud G Gosselin 2003 Sensitization of Ara-C-resistant lymphoma cells by a pronucleotide analogue Int. J. Cancer 107 149 154 10.1002/ijc.11339
4. LP Jordheim E Cros MH Gouy CM Galmarini S Peyrottes J Mackey 2004 Characterization of a gemcitabine-resistant murine leukemic cell line: reversion of in vitro resistance by a mononucleotide prodrug Clin. Cancer Res. 10 5614 5621 10.1158/1078-0432.CCR-04-0506
5. P Couvreur LH Reddy S Mangenot JH Poupaert D Desmaele S Lepetre-Mouelhi 2008 Discovery of new hexagonal supramolecular nanostructures formed by squalenoylation of an anticancer nucleoside analogue Small 4 247 253 10.1002/smll.200700731
6. LH Reddy PE Marque C Dubernet S Lepetre Mouelhi D Desmaele P Couvreur 2008 Preclinical toxicology (sub-acute and acute) and efficacy of a new squalenoyl gemcitabine anticancer nanomedicine J Pharmacol. Exp. Ther. 325 484 490 10.1124/jpet.107.133751
7. B Stella S Arpicco F Rocco V Marsaud JM Renoir L Cattel 2007 Encapsulation of gemcitabine lipophilic derivatives into polycyanoacrylate nanospheres and nanocapsules Int. J. Pharm. 344 71 77 10.1016/j.ijpharm.2007.06. 006
8. T Loftsson ME Brewster 1996 Pharmaceutical applications of cyclodextrins. 1. Drug solubilization and stabilization J. Pharm. Sci. 85 1017 1025 10.1021/js950534b
9. Del Valle, E.M.M.: Cyclodextrins and their uses: a review. Process Biochem. 39, 1033-1046 (2004). doi: 10.1016/S0032-9592(03)00258-9
10. R Bazzanini MH Gouy S Peyrottes G Gosselin C Perigaud S Manfredini 2005 Synthetic approaches to a mononucleotide prodrug of cytarabine Nucleosides Nucleotides Nucleic Acids 24 1635 1649 10.1080/15257770500267006
11. 1H NMR spectroscopic study of the interaction between cyclodextrins and bicyclo[3.3.1]nonanes J. Incl. Phen. 26 209 218 10.1007/BF01053539
12. Grillo, R., de Melo, N.F., Moraes, C.M., de Lima, R., Menezes, C.M., Ferreira, E.I., et al: Study of the interaction between hydroxymethylnitrofurazone and 2-hydroxypropyl-beta-cyclodextrin. J. Pharm. Biomed. Anal. 47, 295-302 (2008). doi: 10.1016/j.jpba.2008.01.010
13. R Ficarra S Tommasini D Raneri ML Calabro MR Di Bella C Rustichelli 2002 Study of flavonoids/beta-cyclodextrins inclusion complexes by NMR, FT-IR, DSC, X-ray investigation J. Pharm. Biomed. Anal. 29 1005 1014 10.1016/S0731-7085(02) 00141-3